CD47 and cancer: Due to the commonly seen increased expression of CD47 in cancer cells, in the last decade, an increasing number of scientists have postulated CD47 as a prognostic factor in several types of tumors; however, evidence of the usefulness of CD47 as a biomarker has not been conclusive for every tumor.